To confirm whether direct epigenetic regulation of PTEN expression was involved in EGFR-TKI resistance in NSCLC cells, we measured the binding ability of H3K9Me2 and H3K9Ac, markers of active gene expression, in PC9/ER and parental cells. This evidence concerns the gene EGFR and non-small cell lung carcinoma.